Puissance Life Science Opportunities Fund Vi is > 10% Shareholder of Bellerophon Therapeutics, Inc.. Currently has a direct ownership of 1.08 Million shares of BLPH, which is worth approximately $53,842. The most recent transaction as insider was on Jun 07, 2023, when has been sold 134,421 shares (Common Stock) at a price of $0.83 per share, resulting in proceeds of $111,569. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.08M
0% 3M change
0% 12M change
Total Value Held $53,842

Puissance Life Science Opportunities Fund VI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2023
SELL
Open market or private sale
$111,569 $0.83 p/Share
134,421 Reduced 11.1%
1,076,841 Common Stock
May 18 2023
SELL
Open market or private sale
$5,297,600 $9.46 p/Share
560,000 Reduced 31.62%
1,211,262 Common Stock
Jun 07 2021
BUY
Grant, award, or other acquisition
$32,756 $4.0 p/Share
8,189 Added 0.46%
1,771,262 Common Stock
Apr 26 2021
BUY
Grant, award, or other acquisition
$2,436,924 $4.0 p/Share
609,231 Added 25.68%
1,763,077 Common Stock
PLS

Puissance Life Science Opportunities Fund Vi

> 10% Shareholder
New York, NY

Track Institutional and Insider Activities on BLPH

Follow Bellerophon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLPH shares.

Notify only if

Insider Trading

Get notified when an Bellerophon Therapeutics, Inc. insider buys or sells BLPH shares.

Notify only if

News

Receive news related to Bellerophon Therapeutics, Inc.

Track Activities on BLPH